Cardiff Oncology (CRDF) Q4 2023 Earnings

29FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.28
-0.26
-0.23
-0.21

Details

Expected EPS
-0.28
Actual EPS
-0.21
Surprise EPS
0.07
Surprise Percent
+25%

Description

Cardiff Oncology (CRDF) has reported earnings of -0.21 per share for Q4 2023.

0 Comments

Share your thoughts